(via Stealthy Gen9 Rolls Out BioFab for Large-Scale Gene Manufacturing | Xconomy)
Related articles
- Gen9, Synthetic Biology Startup, Snags $21M from Agilent (xconomy.com)
- Gen9 lands $21M investment from Agilent Technologies (bostonherald.com)
- Pharma not prepared for big data (worldofdtcmarketing.com)
- The Devil is in the Details: What BioPharma Press Releases Don’t Say (xconomy.com)
TimBatchelder 